Global Squalene Softgel Capsules Market Strategic Research Report
By Type: Deep-sea Shark-derived Squalene Softgel, Plant-derived Squalene Softgel, Synthetic Squalene Softgel, Blended Source Squalene Softgel
By Application: Physical Fatigue Recovery, Immune Function Regulation, Skin Moisturizing & Anti-aging, High-altitude Hypoxia Adaptation
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: KANEKA, Shiseido, DHC, Itou Kampo, Yamamoto Kanpo, NOW Foods, Jarrow Formulas, Swanson, Xiuzheng, BY-HEALTH, Renhe, Conba, UNIMED, Nutriland
概述
Scope of the Report
The global Squalene Softgel Capsules market size is predicted to grow from US$ 1,505 million in 2025 to US$ 2,294 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
In 2024, global annual production capacity for squalene softgel capsules was about 92 million bottles, while actual production reached 65.9 million bottles. The average global retail price was around US$22 per bottle, and profit margins ranged from 30% to 45%, depending on purity levels and sourcing costs. Squalene softgel capsules are dietary supplements containing squalene extracted from shark liver oil or plant sources such as olives and amaranth. Squalene is valued for its antioxidant properties, skin health benefits, and immune-supporting effects. The softgel format improves stability, bioavailability, and ease of consumption.
Upstream includes shark liver oil suppliers, plant-derived squalene extractors (olive, amaranth), gelatin producers, and excipients such as glycerin and antioxidants. Midstream consists of nutraceutical manufacturers responsible for formulation, encapsulation, quality testing, and packaging. Leading producers come from the U.S., Japan, and China. Downstream includes pharmacies, health supplement retailers, e-commerce channels, beauty supplement brands, and wellness clinics. End users focus on purity levels, source transparency (marine vs. plant-based), capsule stability, and compliance with FDA, EFSA, and health supplement regulations.
The global squalene softgel market is expanding due to rising consumer awareness of antioxidant supplements and skin health benefits. Plant-derived squalene is gaining rapid traction as sustainability concerns reduce reliance on shark-derived sources. The beauty-from-within trend and growth in preventive healthcare are further stimulating market demand. Asia-Pacific remains the fastest-growing region, supported by strong supplement consumption habits and e-commerce distribution. Despite competition from other antioxidants such as CoQ10 and vitamin E, squalene maintains a differentiated position in skin hydration and immune support. Manufacturers focusing on plant-based extraction, high purity, and clean-label formulations are expected to gain market share.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Squalene Softgel Capsules market?
What factors are driving Squalene Softgel Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Squalene Softgel Capsules market opportunities vary by end market size?
How does Squalene Softgel Capsules break out by Type, by Application?
This report presents a comprehensive overview of the global Squalene Softgel Capsules market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Deep-sea Shark-derived Squalene Softgel
- Plant-derived Squalene Softgel
- Synthetic Squalene Softgel
- Blended Source Squalene Softgel
Segment by Target Function
- Anti-fatigue Squalene Softgel
- Immune Support Squalene Softgel
- Skin Health Squalene Softgel
- Radiation Resistance Squalene Softgel
Segment by Application
- Physical Fatigue Recovery
- Immune Function Regulation
- Skin Moisturizing & Anti-aging
- High-altitude Hypoxia Adaptation
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Squalene Softgel Capsules market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Physical Fatigue Recovery, Immune Function Regulation, Skin Moisturizing & Anti-aging evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Squalene Softgel Capsules Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Deep-sea Shark-derived Squalene Softgel
- 3.1.3 Plant-derived Squalene Softgel
- 3.1.4 Synthetic Squalene Softgel
- 3.1.5 Blended Source Squalene Softgel
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Physical Fatigue Recovery
- 4.1.3 Immune Function Regulation
- 4.1.4 Skin Moisturizing & Anti-aging
- 4.1.5 High-altitude Hypoxia Adaptation
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 KANEKA
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Shiseido
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 DHC
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Itou Kampo
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Yamamoto Kanpo
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 NOW Foods
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Jarrow Formulas
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Swanson
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Xiuzheng
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 BY-HEALTH
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Renhe
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Conba
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 UNIMED
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Nutriland
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Squalene Softgel Capsules market size?
What growth rate is expected for the Squalene Softgel Capsules market through 2032?
How is Squalene Softgel Capsules defined?
What are the main segments of the Squalene Softgel Capsules market by type?
Which applications drive demand in the Squalene Softgel Capsules market?
Who are the key players in the Squalene Softgel Capsules market?
Which regions and countries are covered for Squalene Softgel Capsules?
What is driving growth in the Squalene Softgel Capsules market?
Who should buy the Squalene Softgel Capsules market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Squalene Softgel Capsules Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Pharmaceuticals